The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cushing Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cushing Syndrome


Psychiatry related information on Cushing Syndrome


High impact information on Cushing Syndrome


Chemical compound and disease context of Cushing Syndrome


Biological context of Cushing Syndrome


Anatomical context of Cushing Syndrome


Gene context of Cushing Syndrome


Analytical, diagnostic and therapeutic context of Cushing Syndrome


  1. Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion. Van Cauter, E., Refetoff, S. N. Engl. J. Med. (1985) [Pubmed]
  2. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. Lacroix, A., Bolté, E., Tremblay, J., Dupré, J., Poitras, P., Fournier, H., Garon, J., Garrel, D., Bayard, F., Taillefer, R. N. Engl. J. Med. (1992) [Pubmed]
  3. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. Estrada, J., Boronat, M., Mielgo, M., Magallón, R., Millan, I., Díez, S., Lucas, T., Barceló, B. N. Engl. J. Med. (1997) [Pubmed]
  4. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. Maton, P.N., Gardner, J.D., Jensen, R.T. N. Engl. J. Med. (1986) [Pubmed]
  5. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. Gold, P.W., Gwirtsman, H., Avgerinos, P.C., Nieman, L.K., Gallucci, W.T., Kaye, W., Jimerson, D., Ebert, M., Rittmaster, R., Loriaux, D.L. N. Engl. J. Med. (1986) [Pubmed]
  6. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. Kalogeras, K.T., Calogero, A.E., Kuribayiashi, T., Khan, I., Gallucci, W.T., Kling, M.A., Chrousos, G.P., Gold, P.W. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  7. Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. Joseph-Vanderpool, J.R., Rosenthal, N.E., Chrousos, G.P., Wehr, T.A., Skwerer, R., Kasper, S., Gold, P.W. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  8. Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study. Pacak, K., Tjurmina, O., Palkovits, M., Goldstein, D.S., Koch, C.A., Hoff, T., Chrousos, G.P. Neuroendocrinology (2002) [Pubmed]
  9. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Magiakou, M.A., Mastorakos, G., Webster, E., Chrousos, G.P. Ann. N. Y. Acad. Sci. (1997) [Pubmed]
  10. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Westphal, C.H., Muller, L., Zhou, A., Zhu, X., Bonner-Weir, S., Schambelan, M., Steiner, D.F., Lindberg, I., Leder, P. Cell (1999) [Pubmed]
  11. Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome. Lacroix, A., Hamet, P., Boutin, J.M. N. Engl. J. Med. (1999) [Pubmed]
  12. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. Lacroix, A., Tremblay, J., Rousseau, G., Bouvier, M., Hamet, P. N. Engl. J. Med. (1997) [Pubmed]
  13. Cushing's syndrome. Orth, D.N. N. Engl. J. Med. (1995) [Pubmed]
  14. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. Magiakou, M.A., Mastorakos, G., Oldfield, E.H., Gomez, M.T., Doppman, J.L., Cutler, G.B., Nieman, L.K., Chrousos, G.P. N. Engl. J. Med. (1994) [Pubmed]
  15. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. Reznik, Y., Allali-Zerah, V., Chayvialle, J.A., Leroyer, R., Leymarie, P., Travert, G., Lebrethon, M.C., Budi, I., Balliere, A.M., Mahoudeau, J. N. Engl. J. Med. (1992) [Pubmed]
  16. Cushing's syndrome: problems in management. Aron, D.C., Findling, J.W., Fitzgerald, P.A., Forsham, P.H., Wilson, C.B., Tyrrell, J.B. Endocr. Rev. (1982) [Pubmed]
  17. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. Huiras, C.M., Pehling, G.B., Caplan, R.H. JAMA (1989) [Pubmed]
  18. Mitotane. Spironolactone antagonism in Cushing's syndrome. Wortsman, J., Soler, N.G. JAMA (1977) [Pubmed]
  19. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. Biller, B.M., Grossman, A.B., Stewart, P.M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A.R., Hofland, L.J., Klibanski, A., Lacroix, A., Lindsay, J.R., Newell-Price, J., Nieman, L.K., Petersenn, S., Sonino, N., Stalla, G.K., Swearingen, B., Vance, M.L., Wass, J.A., Boscaro, M. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  20. Cushing syndrome from percutaneous absorption of triamcinolone cream. May, P., Stein, E.J., Ryter, R.J., Hirsh, F.S., Michel, B., Levy, R.P. Arch. Intern. Med. (1976) [Pubmed]
  21. Surgical management of Cushing's syndrome with emphasis on adrenal autotransplantation. Hardy, J.D. Ann. Surg. (1978) [Pubmed]
  22. Leptin secretion in Cushing's syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone. Weise, M., Abad, V., Considine, R.V., Nieman, L., Rother, K.I. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  23. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. Westerbacka, J., Yki-Järvinen, H., Vehkavaara, S., Häkkinen, A.M., Andrew, R., Wake, D.J., Seckl, J.R., Walker, B.R. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  24. Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome. Shibata, H., Suzuki, H., Maruyama, T., Saruta, T. Hypertension (1995) [Pubmed]
  25. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis. Komanicky, P., Spark, R.F., Melby, J.C. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  26. Endocrine, histological, and biochemical studies of adrenocorticotropin-producing islet cell carcinoma of the pancreas in childhood with characterization of proopiomelanocortin. Styne, D.M., Isaac, R., Miller, W.L., Leisti, S., Connors, M., Conte, F.A., Grumbach, M.M. J. Clin. Endocrinol. Metab. (1983) [Pubmed]
  27. Cushing's syndrome due to ectopic production of corticotropin-releasing factor. Belsky, J.L., Cuello, B., Swanson, L.W., Simmons, D.M., Jarrett, R.M., Braza, F. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  28. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. Rebuffé-Scrive, M., Krotkiewski, M., Elfverson, J., Björntorp, P. J. Clin. Endocrinol. Metab. (1988) [Pubmed]
  29. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol. Imai, T., Sarkar, D., Shibata, A., Funahashi, H., Morita-Matsuyama, T., Kikumori, T., Ohmori, S., Seo, H. Ann. Surg. (2001) [Pubmed]
  30. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. de Herder, W.W., Krenning, E.P., Malchoff, C.D., Hofland, L.J., Reubi, J.C., Kwekkeboom, D.J., Oei, H.Y., Pols, H.A., Bruining, H.A., Nobels, F.R. Am. J. Med. (1994) [Pubmed]
  31. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women. Thomas, M.A., Rebar, R.W., LaBarbera, A.R., Pennington, E.J., Liu, J.H. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  32. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons. Lima, L., Arce, V., Diaz, M.J., Tresguerres, J.A., Devesa, J. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  33. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. Oldfield, E.H., Doppman, J.L., Nieman, L.K., Chrousos, G.P., Miller, D.L., Katz, D.A., Cutler, G.B., Loriaux, D.L. N. Engl. J. Med. (1991) [Pubmed]
  34. Cortisol secretion in Nelson syndrome: Persistence after "total" adrenalectomy for Cushing syndrome. Papapetrou, P.D., Jackson, I. JAMA (1975) [Pubmed]
  35. Primary adrenal causes of Cushing's syndrome. Diagnosis and surgical management. Perry, R.R., Nieman, L.K., Cutler, G.B., Chrousos, G.P., Loriaux, D.L., Doppman, J.L., Travis, W.D., Norton, J.A. Ann. Surg. (1989) [Pubmed]
  36. Effect of glucocorticoids on gastrin secretion in man. Seino, S., Seino, Y., Matsukura, S., Kurahachi, H., Ikeda, M., Yawata, M., Imura, H. Gut (1978) [Pubmed]
  37. EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder. Shipley, J.E., Schteingart, D.E., Tandon, R., Pande, A.C., Grunhaus, L., Haskett, R.F., Starkman, M.N. Biol. Psychiatry (1992) [Pubmed]
WikiGenes - Universities